# Dexmedetomidine and Pregabalin for Conscious Sedation During Cataract Surgery

> **NCT03735368** · PHASE2 · COMPLETED · sponsor: **Abd-Elazeem Abd-Elhameed Elbakry** · enrollment: 60 (actual)

## Conditions studied

- Conscious Sedation

## Interventions

- **DRUG:** Dexmedetomidine Injection
- **DRUG:** Placebo oral capsule
- **DRUG:** Pregabalin Oral Capsule
- **DRUG:** topical anesthesia

## Key facts

- **NCT ID:** NCT03735368
- **Lead sponsor:** Abd-Elazeem Abd-Elhameed Elbakry
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-10
- **Primary completion:** 2019-10-30
- **Final completion:** 2019-11-29
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03735368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03735368, "Dexmedetomidine and Pregabalin for Conscious Sedation During Cataract Surgery". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03735368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*